Official Online Store

MENU

ユーグレナのニュースNews

Press Releases

* Please note that the news release contains the content at the time of the announcement and may differ from the latest information.

2018.03.19

Real Tech Fund Develops Unique Pupillary Light Reflex Analysis System
Invested in "Natsume Sogo Kenkyusho Co., Ltd."

Euglena Investment Co., Ltd.

 Euglena Investment Co., Ltd. (Headquarters: Minato-ku, Tokyo, Representative: Akihiko Nagata) is a new investment destination for the R & D-specialized venture capital fund "Real Tech Fund", Natsume Sogo Kenkyusho Co., Ltd. (hereinafter "Natsume Soken"). We would like to inform you that we have invested in "Company").

 Natsume Sokensha is a company that develops systems and devices that create new value in all business areas such as security, medical care, industrial labor, and living environment, using its own pupillary light reflex analysis system.
 It is known that the human pupil expands in response to interests and interests, but the brightness of the visual object and biological reactions such as respiration and pulse become noise, making precise analysis difficult in the past. The company's pupil analysis technology eliminates the effects on the analysis of biological reactions such as pupil light-dark reaction and respiration / pulse, enabling non-contact measurement that does not require stressful head fixation or terminal attachment to the subject. By doing so, more precise analysis is realized, and it is expected to be applied to polygraph inspection * 1. This pupillary reaction analysis system has been adopted for research by the National Research Institute of Police Science, National Police Agency, and aims to be implemented in society centered on the security area.
* 1 Polygraph inspection: One of the investigation methods used in criminal investigations. Simultaneously measure and record the subject's respiration, blood pressure, pulse, and electrical reaction of the skin to detect falsehood.

 The Real Tech Fund will underwrite the shares issued by Natsume Sokensha through a third-party allotment, and will be adopted by the National Research and Development Corporation New Energy and Industrial Technology Development Organization (NEDO) in FY2017. As a certified VC of the "R & D-type venture support business / commercialization support for R & D-type ventures in the seed period", we will support the company's R & D, sales and marketing activities.
 The details are as follows.

About investment of Natsume Sogo Kenkyusho Co., Ltd.

■ About the outline and support contents of Natsume Sogo Kenkyusho Co., Ltd.
 Date of establishment: July 16, 2013
 location : 6-13 Akashicho, Chuo-ku, Tokyo
 Representative : President and CEO Tadashi Usukura
 Capital : 25.97 million yen (excluding capital reserve)
 Business: Basic research on pupillary analysis, measurement method for utilizing information (data) obtained from pupillary reaction in various fields, analysis logic,
      (Optimization) Solution development, etc.
 HP    : Http://natsumelab.co.jp/
 Support content: Promotion of cooperation with fund-funded companies, support for research and development, sales and marketing activities
 Investment period: October 2017

■ About Realtech Fund (HP: http://www.realtech.fund)Untitled
Our 100% subsidiary of Euglena Investment, SMBC Nikko Securities, Ribanesu "Limited Liability Company was founded three companies Euglena in venture capital funds that SMBC Nikko Ribanesu capital" to management and operation, the investment development of the real tech venture as the main purpose is. With a total of 30 participating companies and a fund size of 9.4 billion yen (as of February 2018), it is Japan's largest fund specializing in real tech. We are investing in and nurturing real-tech ventures together with the operating companies that are our investors.

​ ​

-Contact for inquiries from the press-
Euglena Co., Ltd. Corporate Communication Division

Return to top of page

This website uses cookies to acquire and use access data for the purpose of improving the experience on the site.
When using this site, please agree to the use of cookies.
Please see the "Privacy Policy" for information on site cookies.

agree